David P. Meeker, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), bought 79,525 shares at $17.00 ($425K) on 2017-10-10, disclosed to the SEC on 2017-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 54,525 | $0 | 0.0% |
| 2 | $17.00 | 25,000 | $425K | 100.0% |
| Total | $5.34 avg | 79,525 | $425K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |